 CANTON, Mass., May 06, 2021 GLOBE NEWSWIRE -- Organogenesis Holdings Inc. Nasdaq: ORGO, a leading regenerative medicine company focused on the development, manufacture and commercialization of product solutions for the Advanced Wound Care and Surgical Sports Medicine markets, today announced that the latest advanced wound care research on its PuraPly AM, Affinity, Apligraf, and Nushield product lines will be showcased at the 2021 Symposium on Advanced Wound Care SAWC Spring Wound Healing Society Virtual Experience, held May 10-14. 